Interpharm's Profits Fall In 1995

Interpharm of Israel recorded net profits in 1995 of NIS11.6 million ($3.9 million), down 19.4%. Earnings per share were NIS1.86, also down 19.4%. Gross profits for the year were NIS24.1 million, a decline of 50.8%. The decrease was said to have stemmed from a sharp drop in the quantities sold and in the rate of gross profits of natural interferon beta following a decline in transfer prices, as well as a change in the components of revenues which in 1995 included a larger proportion of revenues from development projects.